[go: up one dir, main page]

GB201818963D0 - Methof for the detection of prostate cancer - Google Patents

Methof for the detection of prostate cancer

Info

Publication number
GB201818963D0
GB201818963D0 GBGB1818963.9A GB201818963A GB201818963D0 GB 201818963 D0 GB201818963 D0 GB 201818963D0 GB 201818963 A GB201818963 A GB 201818963A GB 201818963 D0 GB201818963 D0 GB 201818963D0
Authority
GB
United Kingdom
Prior art keywords
methof
detection
prostate cancer
prostate
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1818963.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Belgian Volition SPRL
Original Assignee
Belgian Volition SPRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Belgian Volition SPRL filed Critical Belgian Volition SPRL
Priority to GBGB1818963.9A priority Critical patent/GB201818963D0/en
Publication of GB201818963D0 publication Critical patent/GB201818963D0/en
Ceased legal-status Critical Current

Links

GBGB1818963.9A 2018-11-21 2018-11-21 Methof for the detection of prostate cancer Ceased GB201818963D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1818963.9A GB201818963D0 (en) 2018-11-21 2018-11-21 Methof for the detection of prostate cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1818963.9A GB201818963D0 (en) 2018-11-21 2018-11-21 Methof for the detection of prostate cancer

Publications (1)

Publication Number Publication Date
GB201818963D0 true GB201818963D0 (en) 2019-01-09

Family

ID=65024364

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1818963.9A Ceased GB201818963D0 (en) 2018-11-21 2018-11-21 Methof for the detection of prostate cancer

Country Status (1)

Country Link
GB (1) GB201818963D0 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019826A1 (en) 2003-08-18 2005-03-03 Chroma Therapeutics Limited Detection of histone modification in cell-free nucleosomes
WO2013030578A2 (en) 2011-09-01 2013-03-07 Singapore Volition Pte Limited Method for detecting nucleosomes
WO2013030577A1 (en) 2011-09-01 2013-03-07 Singapore Volition Pte Limited Method for detecting nucleosomes containing nucleotides
WO2013030579A1 (en) 2011-09-01 2013-03-07 Singapore Volition Pte Limited Method for detecting nucleosomes containing histone variants
WO2013084002A2 (en) 2011-12-07 2013-06-13 Singapore Volition Pte Limited Method for detecting nucleosome adducts
WO2016067029A1 (en) 2014-10-29 2016-05-06 Singapore Volition Pte Limited Method for the enrichment of circulating tumor dna

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019826A1 (en) 2003-08-18 2005-03-03 Chroma Therapeutics Limited Detection of histone modification in cell-free nucleosomes
WO2013030578A2 (en) 2011-09-01 2013-03-07 Singapore Volition Pte Limited Method for detecting nucleosomes
WO2013030577A1 (en) 2011-09-01 2013-03-07 Singapore Volition Pte Limited Method for detecting nucleosomes containing nucleotides
WO2013030579A1 (en) 2011-09-01 2013-03-07 Singapore Volition Pte Limited Method for detecting nucleosomes containing histone variants
WO2013084002A2 (en) 2011-12-07 2013-06-13 Singapore Volition Pte Limited Method for detecting nucleosome adducts
WO2016067029A1 (en) 2014-10-29 2016-05-06 Singapore Volition Pte Limited Method for the enrichment of circulating tumor dna

Non-Patent Citations (23)

* Cited by examiner, † Cited by third party
Title
BLASKO ET AL., INT J RADIAT ONCOL BIOL PHYS, vol. 48, 2000, pages 111
CHADHA ET AL., CLIN CANCER INVESTIG J, vol. 3, 2014, pages 72 - 79
CRAWFORD ET AL., CANCERNETWORK, vol. 28, 2014
CUCHIARRA, EUROPEAN UROLOGY, vol. 73, 2018, pages 572 - 582
DU ET AL., CANCER CHEMOTHER PHARMACOL, vol. 81, 2018, pages 1111 - 1119
FILELLA ET AL., PHARMACOGENOMICS AND PERSONALIZED MEDICINE, vol. 11, 2018, pages 83 - 94
HARRELL JR, RMS, REGRESSION MODELING STRATEGIES, 2018, Retrieved from the Internet <URL:https://CRAN.R-project.org/package=rms>
HEIDEGGER ET AL., PLOS ONE, 2015
MADEJ-MICHNIEWICZ ET AL., NATURE SCIENTIFIC REPORTS, 2015
MARINO-RAMIREZ, L.; LEVINE, K.M.; MORALES, M.; ZHANG, S.; MORELAND, R.T.; BAXEVANIS, A.D.; LANDSMAN, D., THE HISTONE DATABASE: AN INTEGRATED RESOURCE FOR HISTONES AND HISTONE FOLD-CONTAINING PROTEINS, vol. 2011, Retrieved from the Internet <URL:http://genome.nhgri.nih.gov/histones/complete.shtml>
MARTIN ET AL., JAMA, vol. 319, 2018, pages 883 - 895
R CORE TEAM: "R: A language and environment for statistical computing", 2017, R FOUNDATION FOR STATISTICAL COMPUTING
ROBIN ET AL.: "pROC: an open-source package for R and S+ to analyze and compare ROC curves", BMC BIOINFORMATICS, vol. 12, 2017, pages 77
SINGH; LOKESHWAR, MOLECULAR CANCER, vol. 8, 2009
STEPHAN ET AL., CLINICAL CHEMISTRY, vol. 59, 2013, pages 306 - 314
TANIGUCHI; KARIN, SEMINARS IN IMMUNOLOGY, vol. 26, 2014, pages 54 - 74
VELTRI ET AL., UROLOGY, vol. 53, 1999, pages 139 - 47
WANG; SUN, INT J ONOCOLOGY, vol. 44, 2014, pages 1032 - 1040
XIA ET AL., PLOS ONE, 2015
XIE, CYTOKINE AND GROWTH FACTOR REVIEWS, vol. 12, 2001, pages 375 - 391
XU ET AL., CANCER RES, vol. 69, 2009, pages 3267 - 3271
XU ET AL., PLOS ONE, 2012
ZELEFSKY ET AL., INT J RADIAT ONCOL BIOL PHYS, vol. 47, 2000, pages 1261

Similar Documents

Publication Publication Date Title
IL264674B1 (en) Anti-siglec-7 antibodies for the treatment of cancer
IL253756B (en) Biomarker panel for the detection of cancer
IL265697A (en) Treatment of prostate cancer
IL261047A (en) Taf1 inhibitors for the therapy of cancer
IL269879B2 (en) Combination therapy for prostate cancer
PT3490560T (en) Methods of treating prostate cancer
SG11202101397TA (en) Biomarkers for cancer therapy
PL3593139T3 (en) Cancer biomarkers
SG10201913528PA (en) Methods of diagnosing cancer
GB2579328B (en) Breast cancer detection
IL263905A (en) Combination therapy of cancer
GB201602210D0 (en) Detection of cancer
EP3580353A4 (en) Probe combination for detection of cancer
EP3191846A4 (en) Methods of detecting prostate cancer
GB201915469D0 (en) Cancer detection methods
GB201906201D0 (en) Method for the detection of protate cancer
ZA201901578B (en) Combinations including abx196 for the treatment of cancer
GB201814487D0 (en) Cancer
EP3298172A4 (en) Determining risk of prostate cancer recurrence
GB201619808D0 (en) Biomarkers for the prognosis and diagnosis of cancer
GB201818744D0 (en) Detection of bladder cancer
GB201800733D0 (en) Cancer
PL3630754T3 (en) Isoindoline-acetylene compounds for the treatment of cancer
GB201818963D0 (en) Methof for the detection of prostate cancer
GB201906199D0 (en) Method for the detection of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)